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Résumé en
anglais
UNLABELLED: : Stem cell-based regenerative therapies hold great potential for the
treatment of degenerative disorders such as Parkinson's disease (PD). We recently
reported the repair and functional recovery after treatment with human marrow-
isolated adult multilineage inducible (MIAMI) cells adhered to neurotrophin-3 (NT3)
releasing pharmacologically active microcarriers (PAMs) in hemiparkinsonian rats.
In order to comprehend this effect, the goal of the present work was to elucidate the
survival, differentiation, and neuroprotective mechanisms of MIAMI cells and human
neural stem cells (NSCs), both adhering to NT3-releasing PAMs in an ex vivo
organotypic model of nigrostriatal degeneration made from brain sagittal slices. It
was shown that PAMs led to a marked increase in MIAMI cell survival and neuronal
differentiation when releasing NT3. A significant neuroprotective effect of MIAMI
cells adhering to PAMs was also demonstrated. NSCs barely had a neuroprotective
effect and differentiated mostly into dopaminergic neuronal cells when adhering to
PAM-NT3. Moreover, those cells were able to release dopamine in a sufficient
amount to induce a return to baseline levels. Reverse transcription-quantitative
polymerase chain reaction and enzyme-linked immunosorbent assay analyses
identified vascular endothelial growth factor (VEGF) and stanniocalcin-1 as potential
mediators of the neuroprotective effect of MIAMI cells and NSCs, respectively. It
was also shown that VEGF locally stimulated tissue vascularization, which might
improve graft survival, without excluding a direct neuroprotective effect of VEGF on
dopaminergic neurons. These results indicate a prospective interest of human
NSC/PAM and MIAMI cell/PAM complexes in tissue engineering for PD.
SIGNIFICANCE: Stem cell-based regenerative therapies hold great potential for the
treatment of degenerative disorders such as Parkinson's disease (PD). The present
work elucidates and compares the survival, differentiation, and neuroprotective
mechanisms of marrow-isolated adult multilineage inducible cells and human neural
stem cells both adhered to neurotrophin-3-releasing pharmacologically active
microcarriers in an ex vivo organotypic model of PD made from brain sagittal slices.
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